CSRA Down To Strong Sell, Doubt Over NSA &TSA Deal Prevails

 | Jun 21, 2017 10:40PM ET

On Jun 22, CSRA Inc. (NYSE:CSRA) was downgraded to a Zacks Rank #5 (Strong Sell). Going by the Zacks model, companies carrying a Zacks Rank #5 are likely to underperform the broader market in the next one to three months.

Revenue concentration, budgetary constraints, uncertainty related to significant contract renewals and leveraged balance sheet are major concerns for CSRA.

Why the Downgrade?

We note that the National Security Administration’s (NSA) Groundbreaker program and the Transportation Security Administration’s (TSA) Information Technology Infrastructure program that comprise two crucial government programs (making up about 10% of company revenue) are going up for re-compete this year. Hence, the uncertainty over the renewals of TSA and NSA contracts are potential headwinds to CSRA’s industry leading margins, especially as the competition becomes more intense.

Additionally, the delay in awarding the C4ISR systems contract and slow ramp up of the Office of Personnel Management (OPM) background investigations contract has impacted top-line growth in the last reported quarter. Moreover, we expect sluggishness in award procurement to continue in the near term (over the next two quarters), due to numerous ongoing transitions within the Trump administration.

Furthermore, revenue concentration is a major risk for CSRA. In fiscal 2017, 94% of revenues came from sales to the U.S. federal government either as a prime contractor or subcontractor. Due to this massive dependence, any adverse changes in government’s IT spending budget could mar the top-line growth.

Further, CSRA’s leveraged balance sheet adds to the risk of investing in the company. As of Mar 31, 2017, the company had total debt (including the current portion) of $2.58 billion. Meanwhile, it just had $126 million as cash and cash equivalents as of Mar 31, 2017.

On May 24, 2017, CSRA reported fourth-quarter fiscal 2017 results wherein earnings of 49 cents beat the Zacks Consensus Estimate while revenues of $1.25 billion missed the same. On a year over year basis, revenues fell 3%. Also, revenues for the full fiscal were down 4% year over year to $4.99 billion.

Consequently, the company has been seeing downward estimate revisions. In the last 30 days, the Zacks Consensus Estimate for fiscal 2018 declined 4.4% (9 cents) to $1.95 per share while that for fiscal 2019 dropped 2.3% (5 cents) to $2.13 a share.

h3 CSRA Inc. Price and Consensus/h3

Zacks Investment Research

Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes